Company · CIK 0001936258
NewAmsterdam Pharma Co N.V.
NAMSSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$21.36+$0.10 (+0.470%)
NAMS · Last trade
- Prev close
- $21.26
- Range (30d)
- $21.16 – $24.32
On the record
Recent filings
- 8-KNAMSCurrent report0001193125-26-406063 · 243.1 KBSEC(opens sec.gov)
- SCHEDULE 13D/ANAMSNewAmsterdam Pharma Co N.V.0001231919-26-001215 · 108.5 KBSEC(opens sec.gov)
- 8-KNAMSCurrent report0001193125-26-396716 · 207.4 KBSEC(opens sec.gov)
- 144/ANAMSNewAmsterdam Pharma Co N.V.0001968582-26-000878 · 5.1 KBSEC(opens sec.gov)
- 144NAMSNewAmsterdam Pharma Co N.V.0001968582-26-000868 · 5.0 KBSEC(opens sec.gov)
- 8-K/ANAMSNewAmsterdam Pharma Co N.V.0001193125-26-352233 · 214.0 KBSEC(opens sec.gov)
- 8-KNAMSCurrent report0001193125-26-352186 · 207.1 KBSEC(opens sec.gov)
- SCHEDULE 13G/ANAMSNewAmsterdam Pharma Co N.V.0000315066-26-002082 · 11.7 KBSEC(opens sec.gov)
- 8-KNAMSCurrent report0001193125-26-333827 · 868.2 KBSEC(opens sec.gov)
- 10-QNAMSQuarterly update0001193125-26-333824 · 7.7 MBSEC(opens sec.gov)
Insiders
- Audet Juliette BerangereSee Remarks
- Bain Capital Life Sciences Fund III, L.P.10% Owner
- Bain Capital Life Sciences Fund II, L.P.10% Owner
- Bain Capital Life Sciences Investors, LLC10% Owner
- BCIP Life Sciences Associates, LP10% Owner
- BCLS Fund III Investments, LP10% Owner
- BCLS II Investco, LP10% Owner
- Davidson Michael H.Director, Chief Executive Officer
- Downing NicholasDirector
- Forbion Capital Fund IV Cooperatief U.A.10% Owner
Tickers
Addresses
business
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
mailing
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
Former names
- NewAmsterdam Pharma Co B.V.2022-11-22
Same industry